PHYTOCHEMICAL AND THERAPEUTIC PROFILE OF ALOE VERA AND CENTELLA ASIATICA IN REGENERATIVE MEDICINE

Regenerative medicine is rapidly redefining modern therapeutics by focusing on the restoration of damaged tissues through coordinated processes such as wound healing, cellular regeneration, and extracellular matrix remodeling. However, current approaches often remain constrained by high costs, safety concerns, and limited long-term efficacy, prompting a renewed exploration of plant-derived bioactives as next-generation regenerative agents. In this context, Aloe vera and Centella asiatica emerge as two synergistic botanical candidates with remarkable potential in tissue engineering and skin regeneration. Aloe vera, enriched with bioactive polysaccharides such as acemannan along with anthraquinones and micronutrients, functions as a bioactive scaffold that enhances cellular hydration, modulates inflammation, and accelerates epithelial repair. Conversely, Centella asiatica, a rich source of triterpenoids including asiaticoside and madecassoside, acts as a molecular regulator of collagen biosynthesis by stimulating fibroblast proliferation and activating key signaling pathways involved in tissue remodeling. The convergence of these phytochemicals enables a multi-target regenerative response characterized by antioxidant defense, cytokine modulation, angiogenesis, and enhanced extracellular matrix deposition. Notably, emerging evidence suggests that these botanicals can be integrated into advanced delivery systems such as hydrogels, nanocarriers, and bioengineered scaffolds, thereby bridging traditional medicine with modern regenerative technologies. This integrative potential positions them as promising candidates for applications ranging from chronic wound management to anti-aging dermatology. Nevertheless, challenges including phytochemical variability, lack of standardized formulations, and insufficient large-scale clinical validation continue to limit their translational applicability. Future research should emphasize molecular-level investigations, formulation optimization, and clinical trials to unlock their full therapeutic potential in regenerative medicine.